Introduction
Lung masses are usually suspected to represent a malignant process, especially if larger in size than 3 cm. Clinicians rely on radiologic characteristics of the mass to direct their diagnostic approach. [1] [2] [3] Positron emission tomography (PET) or integrated computed tomography and PET (PET/CT), when available, is often considered in the evaluation of lung nodules and masses. The positive predictive value of a positive PET scan exceeds 80%. 4 However, a positive PET scan can also be associated with inflammatory masses or pulmonary sarcoidosis. 5, 6 The most common initial presentations of pulmonary sarcoidosis in adults are bilateral hilar adenopathy or reticulonodular opacities. Although the initial presentation of sarcoidosis as lung nodules is not uncommon, it rarely presents as large lung mass. We report a case of pulmonary sarcoidosis presenting with initial presentation as a lung mass.
Case Report
A 39-year-old African-American woman with a history of ulcerative colitis and tobacco abuse was referred for pulmonary consultation for atypical chest pain and abnormal chest x-ray (CXR). Her symptoms started 3 months prior to the presentation and her review of systems was unrevealing except for a decrease in appetite but without weight loss. Her physical examination was essentially normal and she had no lymphadenopathy or skin lesions. Initial CXR (Figure 1) found bilateral hilar adenopathy. Therefore, a chest CT scan was done which found a concerning mass. Therefore, a PET/CT scan of the chest was done and found mediastinal and hilar lymphadenopathy ( Figure 2 ) and a right lower lobe lung mass ( Figure 3 ) measured 4 cm × 3 cm mass all with significant fluorodeoxyglucose uptake.
Pulmonary function testing was performed and interpreted as follows: no defects, normal diffusion, and minimal air trapping. A CT-guided biopsy of the mass was consistent with nodular, noncaseous granulomas with background fibrous histiocytic infiltration and chronic inflammatory cells in the right lower lung. Based on these findings, the patient underwent videoassisted thoracoscopic surgery that revealed noncaseating granulomas consistent with sarcoidosis. Acid-fast bacilli stain, fungal, and tissue cultures were negative. A bronchoalveolar lavage was not performed. A diagnosis of sarcoidosis was made based on pathologic and radiologic evidence. The patient's symptoms resolved spontaneously without systemic glucocorticoids. 
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women, whereas in Europe, it is highest among white women. Age of onset is between 30 and 45 years of age. 7 Typically, the diagnosis is straightforward based on pathognomonic signs and symptoms. But an atypical presentation often beguiles the medical community and can lead to misdiagnosis. Herein, we present an atypical case of sarcoidosis as a lung mass with no extrapulmonary manifestations.
Diagnosis of sarcoidosis requires 3 elements: (a) radiographic and clinical findings consistent with sarcoidosis, (b) exclusion of diseases that present similarly, and (c) biopsy of the most accessible lesion, demonstrating noncaseating granulomas on histopathology. 8 Sarcoidosis can present with atypical findings on chest radiography and CT scanning of nodules (<3 cm) or masses (>3 cm) that resemble primary or metastatic cancer. 9 Radiographic nodules measure from 1 to 5 cm in diameter that typically consist of coalescent granulomas. 10 These nodules usually tend to be peripheral. Imaging also can consist of bilateral hilar and mediastinal nodal enlargement, which is frequently seen in approximately 75% of the patients. 11 Despite these criteria, sarcoidosis is an everlasting diagnostic challenge. Nodular sarcoidosis is an uncommon form of sarcoidosis and is prevalent in 2.4% to 4% of cases. 12 The first case of nodular sarcoidosis was reported by McCord and Hyman in 1952 with multiple bilateral nodules imitating metastatic disease. 13 Most of the patients with nodular sarcoidosis are African-American women between 20 and 40 years of age. 14 The spontaneous resolution of the disease is common; however, up to 10% of the patients can progress to respiratory impairment and organ failure. There are no established criteria to determine the indications of treatment. The treatment is based on severity of symptoms, evidence of impairment in lung function, and disease with extensive fibrosis and bullae formation. 15 Oral glucocorticoids are the most commonly used medication in the treatment of sarcoidosis. Other alternative therapies such as immunosuppressive and cytotoxic agents have been suggested, but there is limited evidence regarding 
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